Literature DB >> 23063550

Saponins modulate the intracellular trafficking of protein toxins.

Alexander Weng1, Mayank Thakur, Benedicta von Mallinckrodt, Figen Beceren-Braun, Roger Gilabert-Oriol, Burkard Wiesner, Jenny Eichhorst, Stefan Böttger, Matthias F Melzig, Hendrik Fuchs.   

Abstract

Type I ribosome inactivating proteins such as saporin from the plant Saponaria officinalis L. are widely used as toxin moieties of targeted anti-tumor toxins. For exerting cytotoxicity the toxin moieties have to be released into the cytosol of tumor cells. However the cytosolic transfer of toxin molecules into the cytosol is mostly an inefficient process. In this report we demonstrate that certain saponins, which are also biosynthesized by Saponaria officinalis L., specifically mediate the release of saporin out of the intracellular compartments into the cytosol without affecting the integrity of the plasma membrane. The relevant cellular compartments were identified as late endosomes and lysosomes. Further studies revealed that endosomal acidification is a prerequisite for the saponin-mediated release of saporin. Binding analysis demonstrated an association of the saponins with saporin in a pH-dependent manner. The applicability of the saponin-mediated effect was demonstrated in vivo in a syngeneic tumor model using a saporin-based targeted anti-tumor toxin in combination with characterized saponins.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063550     DOI: 10.1016/j.jconrel.2012.10.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  16 in total

Review 1.  Ribosome-inactivating and related proteins.

Authors:  Joachim Schrot; Alexander Weng; Matthias F Melzig
Journal:  Toxins (Basel)       Date:  2015-05-08       Impact factor: 4.546

2.  Reporter assay for endo/lysosomal escape of toxin-based therapeutics.

Authors:  Roger Gilabert-Oriol; Mayank Thakur; Benedicta von Mallinckrodt; Cheenu Bhargava; Burkhard Wiesner; Jenny Eichhorst; Matthias F Melzig; Hendrik Fuchs; Alexander Weng
Journal:  Toxins (Basel)       Date:  2014-05-22       Impact factor: 4.546

Review 3.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 4.  Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers.

Authors:  Nathan Simon; David FitzGerald
Journal:  Toxins (Basel)       Date:  2016-05-04       Impact factor: 4.546

5.  Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.

Authors:  Martijn H den Brok; Christian Büll; Melissa Wassink; Annemarie M de Graaf; Jori A Wagenaars; Marthe Minderman; Mayank Thakur; Sebastian Amigorena; Eric O Rijke; Carla C Schrier; Gosse J Adema
Journal:  Nat Commun       Date:  2016-11-07       Impact factor: 14.919

Review 6.  Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies.

Authors:  Hendrik Fuchs; Nicole Niesler; Alexandra Trautner; Simko Sama; Gerold Jerz; Hossein Panjideh; Alexander Weng
Journal:  Biomedicines       Date:  2017-03-29

7.  Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.

Authors:  Wendy S Smith; David A Johnston; Suzanne E Holmes; Harrison J Wensley; Sopsamorn U Flavell; David J Flavell
Journal:  Toxins (Basel)       Date:  2019-02-20       Impact factor: 4.546

8.  Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins.

Authors:  Javier Ruiz-de-la-Herrán; Jaime Tomé-Amat; Rodrigo Lázaro-Gorines; José G Gavilanes; Javier Lacadena
Journal:  Toxins (Basel)       Date:  2019-10-12       Impact factor: 4.546

Review 9.  Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.

Authors:  Hendrik Fuchs; Alexander Weng; Roger Gilabert-Oriol
Journal:  Toxins (Basel)       Date:  2016-07-01       Impact factor: 4.546

Review 10.  Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties.

Authors:  Jia-Qi Lu; Zhen-Ning Zhu; Yong-Tang Zheng; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2020-03-09       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.